http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-61909-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfd617dc43a4c986d2dd81e4cb39d9dd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-36
filingDate 1988-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d53508d5c6ae0779b109740649978116
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a7d351e7e62ddfe81d217a8407506ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58f4d15e1e8a691a4778b3340454b43e
publicationDate 1994-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-61909-B1
titleOfInvention "Heterocyclic compounds"
abstract The invention relates to a process for producing a (+/-)-3-alkyl-3,4-dihydro-2H-[1,4]benzoxazine derivative of formula (II) by stepwise racemization procedure. The invention further provides a process for optical resolution through the formation of a salt between a (+/-)-benzoxazine compound and an optically active form of camphor-10-sulfonic acid. Without requiring the conventional expensive resolution reagents, this process not only assures production of an optically active isomer of compound (II) in high purity but also permits reuse of the optical resolution reagent.
priorityDate 1987-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID521297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415989640
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448971750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10219718
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31398
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86755044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451363760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426166510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20722760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4353
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10943117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426156530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413305291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415828413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414861975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526858

Total number of triples: 45.